The National Institute for Health and Clinical Excellence (NICE) has just published guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children for England and Wales. This article sets out some of the recommendations and guidelines concentrating...
Forguidanceonusingaspirintopreventvenousthromboembolisminover16sin hospital,seeNICEsguidelineonvenousthromboembolisminover16s:reducing theriskofhospital-acquireddeepveinthrombosisorpulmonaryembolism. NICEssurveillanceteamreviewedtheevidenceaboutaspirinfortheprimary ...
NICE speeds up its obesity guidelinesNICE is due to issue draft guidance on obesity later this month after a joint report from the Healthcare Commission, the Audit Commission and the National Audit Office criticised delays in publishing guidance and said health professionals could be waMA Health...
Guidance for addressing inequities in overweight and obesity Background: Socioeconomic status (SES) imbalances in developed and developing countries may result in individuals being overweight and obese. However, few studies have investigated this issue in Japan. We herein examined the relationship... B...
肥胖:识别、评估和管理临床指南出版日期:2014年11月27日www.nice.org.uk/guidance/cg189?NICE 20 22版权所有。保留所有权利。受限于权利通知(https://www.nice.org.uk/terms-and-条件#权限通知)。 最近更新日期:2022年9月8日肥胖:识别、评估和管理(CG189)您的责任本指导原则中的建议代表了NICE的观点,是在仔...
Williams's negative, even nihilistic, approach to obesity treatment and to sibutramine in particular is ill judged and inaccurate.1 His editorial seems to be based mainly on the limited data from the Sibutramine Cardiovascular Outcomes Trial (SCOUT) released by the European Medicines Agency, and ...
Introducing the updated guidance, Dr Paul Chrisp, director of NICE’s centre for guidelines, said: "Based on evidence, our committee agreed that ear drops containing an anaesthetic and an analgesic may reduce antibiotic consumption and relieve pain in children who did not need immediate antibiotics...
G123(P) Obesity in children and young people with learning disability – Are we following NICE guidance?Aims Obesity among children and young people is increasing. There is limited UK data on obesity in children and young people with... N Taylor,L Stoddart,B Kurup - 《Archives of Disease ...
The article discusses the recommendations and implications of the updated guidance on cardiovascular risk assessment and blood lipids modification released by the National Institute for Health and Care Excellence (NICE). Topics discussed include the use of QRISK2 as cardiovascular risk assessment to preve...
LONDON (Reuters Health) - Britain's National Institute for Clinical Excellence will issue guidance on Wednesday on the use of Abbott's anti-obesity drug Reductil/Meridia (sibutramine), the cost-effectiveness watchdog said on Monday. A positive recommendation is thought likely. NICE has already reco...